Research ArticleImmunology

Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-γ Signaling

See allHide authors and affiliations

Science Signaling  21 Jul 2009:
Vol. 2, Issue 80, pp. ra37
DOI: 10.1126/scisignal.1162191

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Selective Inhibition

Interferon-γ (IFN-γ) activates the Janus kinase–signal transducer and activator of transcription (JAK-STAT) pathway to stimulate the production of the proinflammatory mediators that are required for an appropriate immune response. Defects in a required negative regulatory mechanism mediated by suppressor of cytokine signaling (SOCS) proteins are implicated in chronic inflammatory conditions. DiGiandomenico et al. engineered a cell-penetrating form of SOCS1 (CP-SOCS1) expressed in a human cell line that specifically targeted STAT1 to block IFN-γ–induced production of proinflammatory cytokines and chemokines by macrophages. The application of cell-penetrating proteins produced in human cells has advantages both for research and for potential clinical applications over recombinant proteins purified from bacteria. In addition, CP-SOCS1 may provide a therapeutic strategy against inflammatory diseases.

View Full Text

Stay Connected to Science Signaling